Sight Sciences Q4 2022 revenue up 40% YoY to $20.5M; guides 2023 revenue $89-94M

Sight Sciences, Inc.

Full-year 2022 revenue $71.3M (+46% YoY); Surgical Glaucoma $65.6M (+41%), Dry Eye $5.7M (+133%).
Q4 2022 net loss $16.9M ($0.35/share) vs $15.9M loss ($0.34/share) in Q4 2021.
Q4 2022 operating expenses $33.9M, down 10% sequentially from Q3 2022.
OMNI facilities reached 941 and TearCare facilities grew to 1,042 as of Dec 31, 2022.
2023 revenue guidance $89M-$94M, representing 25%-32% growth over 2022.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

Sight Sciences, Inc. updated its year ending December 31, 2023 guidance (initiated).

Period: year ending December 31, 2023
Guidance: initiated
Result: guidance update

Exact text from the filing

Sight Sciences, Inc. (the "Company") issued a press release announcing its financial results for the four quarter and year ended December 31, 2022 and providing guidance for the year ending December 31, 2023.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Sight Sciences, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $20.5 million, net income $16.9 million, EPS $0.35 per share.

Period: the fourth quarter ended December 31, 2022
Revenue: $20.5 million
Net income: $16.9 million
EPS: $0.35 per share
Result: reported results

Exact text from the filing

31, 2023. Recent Financial Highlights • Generated 2022 total revenue of $71.3 million, an increase of 46% compared to 2021 • Generated fourth quarter 2022 total revenue of $20.5 million, an increase of 40% compared to the prior year period • Reduced fourth quarter 2022 operating expenses by $3.7 million versus the third quarter of 2022 • Improved total gross

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Sight Sciences, Inc. reported the year ended December 31, 2022 results: revenue $71.3 million, net income $86.2 million, EPS $1.80 per share.

Period: the year ended December 31, 2022
Revenue: $71.3 million
Net income: $86.2 million
EPS: $1.80 per share
Result: reported results

Exact text from the filing

quarter and year ended December 31, 2022 and issued financial guidance for the year ending December 31, 2023. Recent Financial Highlights • Generated 2022 total revenue of $71.3 million, an increase of 46% compared to 2021 • Generated fourth quarter 2022 total revenue of $20.5 million, an increase of 40% compared to the prior year period • Reduced fourth quarter

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Sight Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-007578

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.